Literature DB >> 10612762

Autologous porcine heart cell transplantation improved heart function after a myocardial infarction.

R K Li1, R D Weisel, D A Mickle, Z Q Jia, E J Kim, T Sakai, S Tomita, L Schwartz, M Iwanochko, M Husain, R J Cusimano, R J Burns, T M Yau.   

Abstract

OBJECTIVE: Fetal cardiomyocyte transplantation improved heart function after cardiac injury. However, cellular allografts were rejected despite cyclosporine (INN: ciclosporin) therapy. We therefore evaluated autologous heart cell transplantation in an adult swine model of a myocardial infarction.
METHODS: In 16 adult swine a myocardial infarction was created by occlusion of the distal left anterior descending coronary artery by an intraluminal coil. Four weeks after infarction, technetium 99m-sestamibi single photon emission tomography showed minimal perfusion and viability in the infarcted region. Porcine heart cells were isolated and cultured from the interventricular septum at the time of infarction and grown in vitro for 4 weeks. Through a left thoracotomy, either cells (N = 8) or culture medium (N = 8) was injected into the infarct zone.
RESULTS: Four weeks after cell transplantation, technetium 99m-sestamibi single photon emission tomography demonstrated greater wall motion scores in the pigs receiving transplantation than in control animals (P =.01). Pigs receiving transplantation were more likely to have an improvement in perfusion scores (P =.03). Preload recruitable stroke work (P =.009) and end-systolic elastance (P =. 02) were greater in the pigs receiving transplantation than in control animals. Scar areas were not different, but scar thickness was greater (P =.02) in pigs receiving transplantation. Cells labeled with bromodeoxyuridine in vitro could be identified in the infarct zone 4 weeks after transplantation. Swine receiving transplantation gained more weight than control animals (P =.02).
CONCLUSION: Autologous porcine heart cell transplantation improved regional perfusion and global ventricular function after a myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10612762     DOI: 10.1016/s0022-5223(00)70218-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  19 in total

Review 1.  Genetic modification of xenografts.

Authors:  J L Platt
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

Review 2.  Current clinical perspectives on myocardial angiogenesis.

Authors:  Debabrata Mukherjee
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 3.  Stem cell death and survival in heart regeneration and repair.

Authors:  Eltyeb Abdelwahid; Audrone Kalvelyte; Aurimas Stulpinas; Katherine Athayde Teixeira de Carvalho; Luiz Cesar Guarita-Souza; Gabor Foldes
Journal:  Apoptosis       Date:  2016-03       Impact factor: 4.677

Review 4.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

5.  Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

Authors:  Dinender K Singla; Reetu D Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

6.  Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs.

Authors:  Rupak Mukherjee; Juozas A Zavadzkas; Stuart M Saunders; Julie E McLean; Laura B Jeffords; Christy Beck; Robert E Stroud; Allyson M Leone; Christine N Koval; William T Rivers; Shubhayu Basu; Alexander Sheehy; Gene Michal; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

7.  In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems.

Authors:  Courtney Quinn; Alan W Flake
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 8.  Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration.

Authors:  Nobuhisa Ohno; Paul W M Fedak; Richard D Weisel; Masashi Komeda; Donald A G Mickle; Ren-Ke Li
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

9.  Human bone marrow-derived mesenchymal stem cells transplanted into damaged rabbit heart to improve heart function.

Authors:  Jian-an Wang; You-qi Fan; Chang-ling Li; Hong He; Yong Sun; Bin-jian Lv
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

10.  Closed-chest animal model of chronic coronary artery stenosis. Assessment with magnetic resonance imaging.

Authors:  Ming Wu; Jan Bogaert; Jan D'hooge; Karin Sipido; Frederik Maes; Steven Dymarkowski; Frank E Rademakers; Piet Claus
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-10       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.